Search results
Found 7339 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Open Access Update - May 2020
8 May 2020
Risk factors for COVID-19 death revealed in world’s largest analysis of patient records
7 May 2020
The largest study to date, analysing NHS health data from 17.4 million UK adults between 1 February 2020 and 25 April 2020, has given the strongest evidence on risk factors associated with COVID-19 death.
Sharing messages of support
7 May 2020
The Medical Sciences Development team have been working hard to respond to the funding needs of the academics leading research to combat COVID-19. To date, we have raised over £10 million from major gifts and through our public appeal. We have been delighted with the support gained for Oxford’s incredible work, which has attracted gifts from all over the world, as well as closer to home, here in our community.
Major stressors for parents during COVID-19 revealed in new report
7 May 2020
Work was cited as the most frequent source of stress for parents, followed by their children's wellbeing
Managing clinical trials during the pandemic
5 May 2020
Duncan Richards, Climax Professor of Clinical Therapeutics and Director of the Oxford Clinical Trials Research Unit (OCTRU) is interviewed about clinical trials and the challenges of running them in a pandemic.
SEBCOV study launched today
1 May 2020
The SEBCOV study aims to produce evidence to inform public health measures such as communications, quarantine, self-isolation, social distancing, and travel restrictions for the COVID-19 pandemic. This study is run in four countries: UK, Thailand, Italy and Malaysia.
Chan Zuckerberg Initiative awards funding to two Oxford teams to support inflammation research
30 April 2020
Two different teams from the Medical Sciences Division have received a share of $14 million in funding from the Chan Zuckerberg Initiative as one of 29 projects that will explore emerging ideas regarding the role of inflammation in disease.
Practice makes perfect
30 April 2020
Using simulated scenarios to train front-line staff in the COVID-19 response
Results of remdesivir trial released
30 April 2020
The results of a placebo-controlled trial of remdesivir in COVID-19 patients have been published in the Lancet.
Landmark partnership announced for development of COVID-19 vaccine
30 April 2020
The University of Oxford has today announced an agreement with the UK-based global biopharmaceutical company AstraZeneca for the further development, large-scale manufacture and potential distribution of the COVID-19 vaccine candidate currently being trialled by the University.
Oxford Professors honoured by the Royal Society
29 April 2020
Six Oxford University academics, including three from the Medical Sciences Division, have been elected to the prestigious Fellowship of the Royal Society.
Two Medical Sciences professors elected to the National Academy of Sciences
29 April 2020
Professor Kia Nobre (Department of Experimental Psychology) and Professor Fiona Powrie (Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences) are two of 120 new members and 26 new international members newly elected to the National Academy of Sciences in recognition of their distinguished and continuing achievements in original research.
Safeguarding the malaria endgame in the midst of the COVID-19 pandemic
28 April 2020
Blog by Rima Shretta in the Centre for Tropical Medicine & Global Health (Nuffield Department of Medicine). As the COVID-19 pandemic continues its path to LMICs, its impact is likely to be even more devastating, potentially reversing recent gains made in the management of other communicable diseases. Of particular concern is the impact of the COVID-19 pandemic on malaria. COVID-19 has been slow to arrive and spread across Africa; nevertheless, there are many reasons to be concerned about malaria within the current context of the COVID-19 pandemic.